# Prelude Therapeutics Inc: Form 8-K, filed Mar 10, 2026

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: 8-K
- Filed: 2026-03-10
- Accepted by EDGAR: Mar 10, 2026, 08:17 ET
- Period: 2026-03-10
- Accession: 0001193125-26-099424
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000119312526099424/prld-20260310.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000119312526099424/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000119312526099424/prld-20260310.htm

Filed Mar 10, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-099424. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.